Quinoxaline Derivatives as Antiviral Agents: A Systematic Review

Molecules. 2020 Jun 16;25(12):2784. doi: 10.3390/molecules25122784.

Abstract

Background: In recent decades, several viruses have jumped from animals to humans, triggering sizable outbreaks. The current unprecedent outbreak SARS-COV-2 is prompting a search for new cost-effective therapies to combat this deadly pathogen. Suitably functionalized polysubstituted quinoxalines show very interesting biological properties (antiviral, anticancer, and antileishmanial), ensuring them a bright future in medicinal chemistry.

Objectives: Focusing on the promising development of new quinoxaline derivatives as antiviral drugs, this review forms part of our program on the anti-infectious activity of quinoxaline derivatives.

Methods: Study compiles and discusses recently published studies concerning the therapeutic potential of the antiviral activity of quinoxaline derivatives, covering the literature between 2010 and 2020.

Results: A final total of 20 studies included in this review.

Conclusions: This review points to a growing interest in the development of compounds bearing a quinoxaline moiety for antiviral treatment. This promising moiety with different molecular targets warrants further investigation, which may well yield even more encouraging results regarding this scaffold.

Keywords: SAR; antiviral; biological applications; chemistry; quinoxaline.

Publication types

  • Systematic Review

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Betacoronavirus / drug effects*
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • DNA Viruses / drug effects
  • Humans
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Quinoxalines / chemistry
  • Quinoxalines / therapeutic use*
  • SARS-CoV-2
  • Structure-Activity Relationship

Substances

  • Antiviral Agents
  • Quinoxalines